Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000625930 | SCV000746519 | likely pathogenic | Mucopolysaccharidosis, MPS-III-A | 2017-12-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000625930 | SCV000947470 | pathogenic | Mucopolysaccharidosis, MPS-III-A | 2023-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 271 of the SGSH protein (p.Thr271Met). This variant is present in population databases (no rsID available, gnomAD 0.003%). This missense change has been observed in individuals with SGSH-related conditions (PMID: 21204211, 28844463). ClinVar contains an entry for this variant (Variation ID: 522769). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SGSH protein function. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000625930 | SCV002778527 | likely pathogenic | Mucopolysaccharidosis, MPS-III-A | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000625930 | SCV004201120 | pathogenic | Mucopolysaccharidosis, MPS-III-A | 2023-05-11 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000625930 | SCV001463879 | likely pathogenic | Mucopolysaccharidosis, MPS-III-A | 2020-09-16 | no assertion criteria provided | clinical testing |